top of page

Latest News

1 Dec 2025

The NEAT ID Foundation announces publication in The Lancet Infectious Diseases from the Late Presenter Treatment Optimization (LAPTOP) study - the largest randomized clinical trial to date dedicated to identifying optimal first-line antiretroviral therapy for people with advanced HIV disease.

7 Nov 2025

NEAT ID Publication in HIV Medicine: New Study Highlights Key Risk Factors for Severe COVID-19 in People Living with HIV

6 Nov 2025

NEAT ID Foundation Marks a Successful Presence at EACS 2025 in Paris

15 Oct 2025

NEAT ID e-poster presentation at EACS 2025: Results from the “DREW” Study

15 Oct 2025

NEAT ID Rapid Oral Abstract Presentation at EACS 2025: Results from the “MASH-1” Study.

Mpox-Related Hospitalization Higher in People Living with HIV: European MASH-1 Cohort Data Presented at EACS 2025

27 Aug 2025

Dr. Geoffroy Liegeon Awarded NEAT ID Young Investigator of the Year Award 2025

14 Jul 2025

Poster Presentation at IAS 2025: Results from the “C2C” Study

1 Jul 2025

NEAT ID Publication in AIDS July 2025 Edition: New European Study Confirms Effectiveness and Safety of Doravirine-Based HIV Regimens in Real-World Settings

23 Apr 2025

Poster Presentation at BHIVA 2025: Results from the FOST Switch Study on Fostemsavir in HIV Treatment

14 Apr 2025

NEAT ID, The European treatment network of HIV, hepatitis and global emerging infectious diseases has appointed Dr Esteban Martinez, MD, as President.

8 Mar 2025

European clinical scientists from the NEAT ID Network present LAte Presenter Treatment OPtimisation (LAPTOP) Study results for the first time at the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 in San Francisco. The LAPTOP Study is the first fully powered head-to-head trial in this particularly vulnerable patient group

bottom of page